DEERFIELD -
The TCFD framework is designed to help improve climate-related disclosure that is relevant to Baxter s investors and other key stakeholders in the areas of governance, strategy, risk management, and metrics and targets. The publication of the TCFD report comes as Baxter is named to the
Continuously enhancing our reporting on climate-related topics that our stakeholders prioritize is a core and longstanding tenet of Baxter s corporate responsibility approach, said
Baxter s TCFD report includes information on the company s management of climate-related risks and opportunities. Baxter is committed to transparency and strong disclosure in this area, as the company drives progress toward its goal to achieve carbon neutrality for its direct operations by 2040 and reduce absolute Scope 1 and 2 greenhouse gas emissions 25% by 2030, aligned with a well-below 2 Celsius science-based target. The TCFD report complements Baxter s annual Corporate Responsibility Report,
About Corporate Responsibility at Baxter: Making a Meaningful Difference Worldwide
Responsible corporate citizenship advances Baxter s aspirations as a healthcare leader, sparks innovation globally and reinforces the dedication of our employees to doing business the right way. Our commitment to Empower our Patients, Protect our Planet, and Champion our People and Communities guides our efforts as a socially responsible and sustainable business and as an employer of choice focused on diversity, equity and inclusion. We recently maintained our EcoVadis Gold Sustainability Rating and were included in 2023 on the FTSE Russell s
About Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter s employees worldwide are now building upon the company s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
This release includes forward-looking statements concerning Baxter s expectations about future TCFD disclosures, carbon neutrality and emissions goals. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities (including with respect to climate change and other sustainability matters); changes in law and regulations; Baxter s ability to execute on capital allocation plans; the occurrence of manufacturing difficulties; future actions of third parties and other risks identified in Baxter s most recent filing on Form 10-K and other
Contact:
Tel: 1-224-948-5353
Email: media@baxter.com
(C) 2023 Electronic News Publishing, source